KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Debt Ratio (2018 - 2025)

Esperion Therapeutics (ESPR) has disclosed Debt Ratio for 3 consecutive years, with 0.33 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 20.31% year-over-year to 0.33, compared with a TTM value of 0.33 through Dec 2025, down 20.31%, and an annual FY2025 reading of 0.33, down 20.31% over the prior year.
  • Debt Ratio was 0.33 for Q4 2025 at Esperion Therapeutics, down from 0.42 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.44 in Q1 2025 and bottomed at 0.33 in Q4 2025.